Nav: Home

Progesterone is effective for hot flash treatment and provides an alternative to estrogen

June 21, 2010

Postmenopausal women who experience bothersome hot flashes or night sweats may have an alternative treatment to estrogen. According to a new study, oral micronized progesterone relieves those symptoms. The results will be presented Saturday at The Endocrine Society's 92nd Annual Meeting in San Diego.

"This is the first evidence that oral micronized progesterone, which is molecularly identical to the natural hormone, is effective for women with symptomatic hot flashes," said the presenting author, Jerilynn Prior, MD, professor, University of British Columbia, Vancouver, Canada.

Available only by prescription and sold under the brand name Prometrium in the United States and Canada, this form of progesterone is manufactured from a steroid in yams.

"Vasomotor symptoms"--hot flashes (sometimes called hot flushes) and night sweats--are experienced by most women during the years around the final menstrual period. In the most symptomatic women (at least 5-10%) these symptoms disturb sleep, energy and quality of life, Prior said.

The researchers recruited 114 healthy postmenopausal women seeking hormonal therapy for hot flashes and night sweats and randomly assigned them to take either oral micronized progesterone or an inactive substance (placebo), both as three round capsules at bedtime. Neither the women nor the study team members were aware which treatment the study participants received during the three months of therapy. The time since their last menstrual flow was one to 10 years, with an average of four years. To be eligible to participate in the study, women could not have taken ovarian hormone therapy within the past six months.

Prior and Christine Hitchcock, PhD, of the University of British Columbia, calculated the average daily vasomotor symptom score, or VMSScore, from the data that subjects recorded in a daily diary. This score reflects both intensity and number for hot flashes and night sweats each day.

Progesterone, in a 300-milligram dose, was more effective than placebo at decreasing the intensity and number of symptoms, the authors reported, and the difference was both statistically significant and clinically important. The 68 women taking progesterone showed a 56% improvement from baseline in VMSScore, and a 48% reduction in the number of VMS; the 46 women taking placebo had 28% lower VMSScores and a 22% reduction in number.

"Women improve very quickly on oral micronized progesterone. The improvement is apparent within the first 4 weeks," Prior said.

Micronized progesterone did not cause any serious side effects, she said. The drug may be an option for postmenopausal women who do not want to or should not take estrogen--"currently the only effective therapy for decreasing severe vasomotor symptoms," Prior said.
-end-
Besins Healthcare and Schering Canada donated the progesterone and placebo for this study.

The Endocrine Society

Related Estrogen Articles:

How estrogen modulates fear learning
Low estrogen levels may make women more susceptible to the development of post-traumatic stress disorder (PTSD), while high estrogen levels may be protective.
Estrogen signaling impacted immune response in cancer
New research from The Wistar Institute showed that estrogen signaling was responsible for immunosuppressive effects in the tumor microenvironment across cancer types.
Are drops in estrogen levels more rapid in women with migraine?
Researchers have long known that sex hormones such as estrogen play a role in migraine.
Estrogen-deficient female athletes' memory improves with estrogen
In young female athletes who stop having their menstrual periods because of excessive exercise, estrogen replacement appears to improve their memory, a new study finds.
Blood clot risk lower for estrogen-only, transdermal, and vaginal estrogen at menopause
A Swedish population study is helping answer lingering questions about hormone therapy safety.
U of G researchers study tie between estrogen, memory
A new study by University of Guelph researchers that narrows down where and how estrogens affect the brain may help in understanding how the hormones affect cognition and memory in women.
New sensor sends electronic signal when estrogen is detected
Researchers in New Zealand have developed a new sensor that can detect low levels of E2, one of the primary estrogen hormones, in liquids.
Estrogen drug may not benefit women with Alzheimer's dementia
An estrogen-like drug, raloxifene, has no demonstrated benefit on memory and thinking skills for women with dementia due to Alzheimer's disease, according to a study published in the Nov.
Panel recommends improvements in estrogen testing accuracy
Unreliable estrogen measurements have had a negative impact on the treatment of and research into many hormone-related cancers and chronic conditions.
Interaction of estrogen receptor and coactivators seen for first time
In a recent study with Dr. Wah Chiu, professor of biochemistry and molecular biology at Baylor, O'Malley for the first time visualized the 900 kiloDalton molecular machine made up of the receptor, its coactivator SRC-3, another coactivator called p300, and the DNA that it controls, through the use of an electron cryo-microscope and advanced computational analysis.

Related Estrogen Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...